A novel treatment for ameliorating retinal vascular disease [ 2012 - 2014 ]

Research Grant

Researchers: Prof Erica Fletcher (Principal investigator) ,  Mr Malcolm Plunkett ,  Prof Jennifer Wilkinson-Berka ,  Prof Mark Gillies

Brief description Retinal vascular disease is a leading cause of blindness and is currently treated by laser photocoagulation surgery. Although successful, this treatment is associated with serious side effects. Recently, Ellex Pty has developed a novel laser called the 2RT laser that is likely to be effective without the accompanying side effects. This study will allow examine the effect of the 2RT laser in animal models of retinal vascular disease so as to complete preclinical development of this laser.

Funding Amount $AUD 366,685.51

Funding Scheme NHMRC Development Grants

Notes Development Grant